Bacteriophage mediates efficient gene transfer in combination with conventional transfection reagents

Viruses

Volumn 7, Issue 12, 2015, Pages 6476-6489

  Donnelly, Amanda ^a   Yata, Teerapong ^a,b   Bentayebi, Kaoutar ^c   Suwan, Keittisak ^a   Hajitou, Amin ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Bacteriophage; Calcium phosphate; Phage biotechnology; Phage based gene delivery; Transfection

Indexed keywords

(N [1 (2,3 DIOLEOYLOXY)PROPYL] N,N,N TRIMETHYL AMMONIUM METHYL SULFATE); CALCIUM PHOSPHATE; GREEN FLUORESCENT PROTEIN; LIGAND; LIPID; LIPOFECTAMINE; POLYETHYLENEIMINE; REAGENT; UNCLASSIFIED DRUG; VIRUS VECTOR; POLYMER;

ADENO ASSOCIATED VIRUS 2; ARTICLE; CELL VIABILITY ASSAY; CHEMICAL MODIFICATION; CLONING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENTEROBACTERIA PHAGE M13; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO GENE TRANSFER; INTERNALIZATION; INVERTED TERMINAL REPEAT; LUCIFERASE ASSAY; MCF 7 CELL LINE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; CELL LINE; GENETICS;

BACTERIOPHAGE M13; CALCIUM PHOSPHATES; CELL LINE; HUMANS; LIPIDS; POLYMERS; TRANSFECTION;

EID: 84949523887     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7122951     Document Type: Article

References (31)

1. Baldi, L.; Hacker, D.L.; Adam, M.; Wurm, F.M. Recombinant protein production by large-scale transient gene expression in mammalian cells: State of the art and future perspectives. Biotechnol. Lett. 2007, 29, 677-684. [CrossRef] [PubMed]
2. Chiou, H.C.; Vasu, S.; Liu, C.Y.; Cisneros, I.; Jones, M.B.; Zmuda, J.F. Scalable transient protein expression. Methods Mol. Biol. 2014, 1104, 35-55. [PubMed]
3. Verma, I.M.; Weitzman, M.D. Gene therapy: Twenty-first century medicine. Ann. Rev. Biochem. 2005, 74, 711-738. [CrossRef] [PubMed]
4. Graham, F.L.; van der Eb, A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52, 456-467. [CrossRef]
5. Islam, M.A.; Park, T.E.; Singh, B.; Maharjan, S.; Firdous, J.; Cho, M.H.; Kang, S.K.; Yun, C.H.; Choi, Y.J.; Cho, C.S. Major degradable polycations as carriers for DNA and siRNA. J. Controll. 2014, 193, 74-89. [CrossRef] [PubMed]
6. Aoshima, Y.; Hokama, R.; Sou, K.; Sarker, S.R.; Iida, K.; Nakamura, H.; Inoue, T.; Takeoka, S. Cationic amino acid based lipids as effective nonviral gene delivery vectors for primary cultured neurons. ACS Chem. Neurosci. 2013, 4, 1514-1519. [CrossRef] [PubMed]
7. Giacca, M.; Zacchigna, S. Virus-mediated gene delivery for human gene therapy. J. Controll. Release 2012, 161, 377-388. [CrossRef] [PubMed]
8. Kotterman, M.A.; Schaffer, D.V. Engineering adeno-associated viruses for clinical gene therapy. Nat. Rev. Genet. 2014, 15, 445-451. [CrossRef] [PubMed]
9. Capasso, C.; Garofalo, M.; Hirvinen, M.; Cerullo, V. The evolution of adenoviral vectors through genetic and chemical surface modifications. Viruses 2014, 6, 832-855. [CrossRef] [PubMed]
10. Ariga, T. A possible turning point in the hematopoietic stem cell gene therapy for primary immunodeficiency diseases? Lentiviral vectors could take the place of retroviral vectors. Expert Rev. Clin. Immunol. 2013, 9, 1015-1018. [CrossRef] [PubMed]
11. Biffi, A.; Montini, E.; Lorioli, L.; Cesani, M.; Fumagalli, F.; Plati, T.; Baldoli, C.; Martino, S.; Calabria, A.; Canale, S.; et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 2013, 341, 1233158. [CrossRef] [PubMed]
12. Hajitou, A.; Lev, D.C.; Hannay, J.A.; Korchin, B.; Staquicini, F.I.; Soghomonyan, S.; Alauddin, M.M.; Benjamin, R.S.; Pollock, R.E.; Gelovani, J.G.; et al. A preclinical model for predicting drug response in soft-tissue sarcoma with targeted aavp molecular imaging. Proc. Natl. Acad. Sci. USA 2008, 105, 4471-4476. [CrossRef] [PubMed]
13. Hajitou, A.; Rangel, R.; Trepel, M.; Soghomonyan, S.; Gelovani, J.G.; Alauddin, M.M.; Pasqualini, R.; Arap, W. Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat. Protoc. 2007, 2, 523-531. [CrossRef] [PubMed]
14. Hajitou, A.; Trepel, M.; Lilley, C.E.; Soghomonyan, S.; Alauddin, M.M.; Marini, F.C., 3rd; Restel, B.H.; Ozawa, M.G.; Moya, C.A.; Rangel, R.; et al. A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 2006, 125, 385-398. [CrossRef] [PubMed]
15. Pranjol, M.Z.; Hajitou, A. Bacteriophage-derived vectors for targeted cancer gene therapy. Viruses 2015, 7, 268-284. [CrossRef] [PubMed]
16. Lang, L.H. FDA approves use of bacteriophages to be added to meat and poultry products. Gastroenterology 2006, 131, 1370. [PubMed]
17. Atterbury, R.J. Bacteriophage biocontrol in animals and meat products. Microb. Biotechnol. 2009, 2, 601-612. [CrossRef] [PubMed]
18. Mima, H.; Tomoshige, R.; Kanamori, T.; Tabata, Y.; Yamamoto, S.; Ito, S.; Tamai, K.; Kaneda, Y. Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector. J. Gene Med. 2005, 7, 888-897. [CrossRef] [PubMed]
19. Zhao, C.; Wu, N.; Deng, F.; Zhang, H.; Wang, N.; Zhang, W.; Chen, X.; Wen, S.; Zhang, J.; Yin, L.; et al. Adenovirus-mediated gene transfer in mesenchymal stem cells can be significantly enhanced by the cationic polymer polybrene. PLoS ONE 2014, 9, e92908. [CrossRef] [PubMed]
20. Stoneham, C.A.; Hollinshead, M.; Hajitou, A. Clathrin-mediated endocytosis and subsequent endo-lysosomal trafficking of adeno-associated virus/phage. J. Biol. Chem. 2012, 287, 35849-35859. [CrossRef] [PubMed]
21. Kim, T.K.; Eberwine, J.H. Mammalian cell transfection: The present and the future. Anal. Bioanal. Chem. 2010, 397, 3173-3178. [CrossRef] [PubMed]
22. Yata, T.; Lee, K.Y.; Dharakul, T.; Songsivilai, S.; Bismarck, A.; Mintz, P.J.; Hajitou, A. Hybrid nanomaterial complexes for advanced phage-guided gene delivery. Mol. Ther. Nucl. Acids 2014, 3, e185. [CrossRef] [PubMed]
23. Hajitou, A. Targeted systemic gene therapy and molecular imaging of cancer contribution of the vascular-targeted AAVP vector. Adv. Genet. 2010, 69, 65-82. [PubMed]
24. Yata, T.; Lee, E.L.; Suwan, K.; Syed, N.; Asavarut, P.; Hajitou, A. Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors. Mol. Cancer 2015, 14, 110. [CrossRef] [PubMed]
25. Kia, A.; Przystal, J.M.; Nianiaris, N.; Mazarakis, N.D.; Mintz, P.J.; Hajitou, A. Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression. Mol. Cancer Ther. 2012, 11, 2566-2577. [CrossRef] [PubMed]
26. Gillet, J.P.; Macadangdang, B.; Fathke, R.L.; Gottesman, M.M.; Kimchi-Sarfaty, C. The development of gene therapy: From monogenic recessive disorders to complex diseases such as cancer. Methods Mol. Biol. 2009, 542, 5-54. [PubMed]
27. Wang, D.; Gao, G. State-of-the-art human gene therapy: Part II. Gene therapy strategies and clinical applications. Discov. Med. 2014, 18, 151-161. [PubMed]
28. Kay, M.A.; Glorioso, J.C.; Naldini, L. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat. Med. 2001, 7, 33-40. [CrossRef] [PubMed]
29. Warnock, J.N.; Daigre, C.; Al-Rubeai, M. Introduction to viral vectors. Methods Mol. Biol. 2011, 737, 1-25. [PubMed]
30. Keswani, R.; Su, K.; Pack, D.W. Efficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectors. J. Controll. Release 2014, 192, 40-46. [CrossRef] [PubMed]
31. Jang, J.H.; Schaffer, D.V.; Shea, L.D. Engineering biomaterial systems to enhance viral vector gene delivery. Mol. Ther. 2011, 19, 1407-1415. [CrossRef] [PubMed]